ECC5004 DDI Study With Atorvastatin, Rosuvastatin, Digoxin and Midazolam in Healthy Participants
Conditions: Type 2 Diabetes Mellitus Interventions: Drug: ECC5004; Drug: Midazolam; Drug: Rosuvastatin; Drug: Digoxin; Drug: Atorvastatin Sponsors: Eccogene Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Atorvastatin Calcium | Crestor | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Lipitor | Research | Rosuvastatin | Statin Therapy | Study | Zivast